A Study Comparing an Investigational Wound Gel With Standard Treatment for Mild to Moderate Diabetic Foot Ulcers
A Multicenter, Randomized Controlled Trial of VES-0-D Gel, an Investigational Alginol, Versus Standard Care in the Management of Wagner Grade 1 or 2 Diabetic Foot Ulcers Over 8 Weeks
Flen Health
64 participants
Aug 10, 2026
INTERVENTIONAL
Conditions
Summary
The goal of this clinical investigation is to evaluate if VES-0-D (an investigational wound gel) works to treat mild to moderate Diabetic Foot Ulcers. The main question it aims to answer is: How well does VES-0-D gel support wound healing, compared with a standard wound treatment? Other questions that are the target of the investigation are: * the evaluation of wound characteristics relevant to healing * the evaluation of side effects at the site of application The investigation will compare the wound area reduction over the 8 week treatment for VES-0-D vs standard of care treated patients. The investigation will also collect wound assessment scoring results over the entire study duration as well as safety data on VES-0-D. Participants will: Have VES-0-D or standard of care applied every 3-4 days for 8 weeks, either at home or in the clinic Visit the clinic once every week for checkups and assessments. Keep a diary of their applications and any symptoms they might experience
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
VES-0-D Gel is a non-invasive topical medical device intended to manage moisture levels at the surface of open wounds
Standard of care wound dressing will be chosen by the treating physician
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07783087